Topline

shape

Homepage Companies Amal Therapeutics

Amal Therapeutics

Locations: 64 av., de la Roseraie Geneva, 1205, CH

Company Size: 1 - 100

Industry: Biotechnology Research

Company Website

AI Description

Laetitia Devy-Dimanche

CEO at AMAL Therapeutics SA

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Stéphane Costa Borges

Protein Research Assistant chez Amal Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Wilma Besson

Assistant Research Scientist chez Amal Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Cristina Riccadonna

Clinical Trial Manager at AMAL Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Magali DEJOB

CMC Team Leader chez Amal Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Francesca Alfei

Scientist, Cancer Immunology and Immune Modulation

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.
Matteo Rossi

Head of in vivo Research at Amal Therapeutics

View Details

Gold Feature:
Click to upgrade to our gold package for the full feature experience.

Showing 1 to 7 of 13 results

‹ Prev 1 2 Next ›